906
Views
5
CrossRef citations to date
0
Altmetric
Retracted Article

RETRACTED ARTICLE: Cdc25C/cdc2/cyclin B, raf/MEK/ERK and PERK/eIF2α/CHOP pathways are involved in forskolin-induced growth inhibition of MM.1S cells by G2/M arrest and mitochondrion-dependent apoptosis

, ORCID Icon, , , , , , , , , , & ORCID Icon show all
Pages 2402-2412 | Received 08 Jun 2020, Accepted 14 Sep 2021, Published online: 04 Oct 2021
 

Statement of Retraction

We, the Editors and Publisher of the Cell Cycle journal, have retracted the following article:

Ping Yang, Pei-Wen Jiang, Chen Li, Ming-Xiang Gao, Yi-Song Sun, Dan-Ying Zhang, Wen-Qian Du, Jing Zhao, Song-Ting Shi, Yan Li, Tai Yang, Li Cheng and Min-Hui Li. Cdc25C/cdc2/cyclin B, raf/MEK/ERK and PERK/eIF2α/CHOP pathways are involved in forskolin-induced growth inhibition of MM.1S cells by G2/M arrest and mitochondrion-dependent apoptosis. Cell Cycle. 2020;20(22):2402-2412. doi: 10.1080/15384101.2021.1983280

Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors were cooperative, however, they have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors have agreed to retract the article.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

View retraction statement:
Statement of Retraction: Cdc25C/cdc2/cyclin B, raf/MEK/ERK and PERK/eIF2α/CHOP pathways are involved in forskolin-induced growth inhibition of MM.1S cells by G2/M arrest and mitochondrion-dependent apoptosis

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.